Stina Jakobsson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Stina Jakobsson has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Thomas Mooe
Umeå University
2 shared publications Anders Ulvenstam
From the Department of Public Health and Clinical Medicine, Umeå University, Sweden (A.B., S.J., T.M.); and Department of Internal Medicine, Section of Cardiology, Östersund Hospital, Sweden (A.U., T.M.).
1 shared publication- Anders Ulvenstam
Department of Public Health and Clinical Medicine, Umeå University , Umeå
1 shared publication Ann-Charlott Docherty Skogh
Department of Reconstructive Plastic Surgery, Karolinska University Hospital, 17176 Stockholm, Sweden
1 shared publicationAnna Brammås
From the Department of Public Health and Clinical Medicine, Umeå University, Sweden (A.B., S.J., T.M.); and Department of Internal Medicine, Section of Cardiology, Östersund Hospital, Sweden (A.U., T.M.).
1 shared publication- Anna Graipe
Section of Cardiology Department of Internal Medicine Östersund Hospital Östersund Sweden
1 shared publication
Latest Publications
- Open Access
- 21 July 2026
- Published by Oxford University Press (OUP) in Neuro-Oncology Practice
Persistent fatigue after surgery for asymptomatic meningiomas: A population-based long-term follow-up study
Background: Meningiomas are increasingly detected incidentally due to widespread neuroimaging and are sometimes managed surgically despite the absence of preoperative symptoms. Although surgery in these patients is often considered to be of low risk, long-term patient-reported outcomes such as fatigue remain insufficiently characterized. Objective: To assess the prevalence and severity of long-term fatigue in patients surgically treated for asymptomatic meningiomas. Methods: In this population-based retrospective cohort study, adult (≥18 years) patients with asymptomatic meningioma treated surgically at Karolinska University Hospital between 2007 and 2013 (n = 69) were included. Patients were assessed using the Multidimensional Fatigue Inventory (MFI-20) and compared with age- and sex-matched normative values. The proportion of patients with clinically significant fatigue was estimated using validated cut-off scores based on previous studies. Results: The median total fatigue score was 55 (IQR 45-63), corresponding to approximately 0.7 SDs above age- and sex-matched normative values. Patients reported significantly higher fatigue levels than normative values across all MFI-20 dimensions (all P < .001). Fatigue was present in 33% of patients based on total fatigue scores, while 48%-64% exceeded cut-off values in individual fatigue dimensions present in MFI-20. Descriptive differences in fatigue scores were observed across age groups and between sexes Conclusion: Patients surgically treated for asymptomatic meningiomas experience elevated multidimensional fatigue at long-term follow-up. These findings challenge assumptions of benign postoperative recovery in this patient population and highlight the importance of systematic fatigue assessment and targeted management strategies even in previously asymptomatic patients.
- 21 July 2026
- Published by Oxford University Press (OUP) in Neuro-Oncology Practice
Open AccessPersistent fatigue after surgery for asymptomatic meningiomas: A population-based long-term follow-up study
Background: Meningiomas are increasingly detected incidentally due to widespread neuroimaging and are sometimes managed surgically despite the absence of preoperative symptoms. Although surgery in these patients is often considered to be of low risk, long-term patient-reported outcomes such as fatigue remain insufficiently characterized. Objective: To assess the prevalence and severity of long-term fatigue in patients surgically treated for asymptomatic meningiomas. Methods: In this population-based retrospective cohort study, adult (≥18 years) patients with asymptomatic meningioma treated surgically at Karolinska University Hospital between 2007 and 2013 (n = 69) were included. Patients were assessed using the Multidimensional Fatigue Inventory (MFI-20) and compared with age- and sex-matched normative values. The proportion of patients with clinically significant fatigue was estimated using validated cut-off scores based on previous studies. Results: The median total fatigue score was 55 (IQR 45-63), corresponding to approximately 0.7 SDs above age- and sex-matched normative values. Patients reported significantly higher fatigue levels than normative values across all MFI-20 dimensions (all P < .001). Fatigue was present in 33% of patients based on total fatigue scores, while 48%-64% exceeded cut-off values in individual fatigue dimensions present in MFI-20. Descriptive differences in fatigue scores were observed across age groups and between sexes Conclusion: Patients surgically treated for asymptomatic meningiomas experience elevated multidimensional fatigue at long-term follow-up. These findings challenge assumptions of benign postoperative recovery in this patient population and highlight the importance of systematic fatigue assessment and targeted management strategies even in previously asymptomatic patients.
- Open Access
- 5 January 2026
- Published by Elsevier in JPRAS Open
- Vol. 48, 669-678
Artificial intelligence as a surgical advisor before a DIEP breast reconstruction. A blinded comparative study of three large language models
- 5 January 2026
- Published by Elsevier in JPRAS Open
- Vol. 48, 669-678
Open AccessArtificial intelligence as a surgical advisor before a DIEP breast reconstruction. A blinded comparative study of three large language models
- Open Access
- 15 August 2014
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 3 (3) , e42
The Nurse-Based Age Independent Intervention to Limit Evolution of Disease After Acute Coronary Syndrome (NAILED ACS) Risk Factor Trial: Protocol for a Randomized Controlled Trial
Background: Secondary prevention after acute coronary syndrome (ACS) is essential to reduce morbidity and mortality, but related studies have been fairly small or performed as clinical trials with non-representative patient selection. Long-term follow-up data are also minimal. A nurse-led follow-up for risk factor improvement may be effective, but the evidence is limited. Objective: The aims of this study are to perform an adequately sized, nurse-led, long-term secondary preventive follow-up with inclusion of an unselected population of ACS patients. The focus will be on lipid and blood pressure control as well as tobacco use and physical activity. Methods: The study will consist of a randomized, controlled, long-term, population-based trial with two parallel groups. Patients will be included during the initial hospital stay. Important outcome variables are total cholesterol, low-density lipoprotein (LDL) cholesterol, and sitting systolic and diastolic blood pressure. Outcomes will be measured after 12, 24, and 36 months of follow-up. Trained nurses will manage the intervention group with the aim of achieving set treatment goals as soon as possible. The control group will receive usual care. At least 250 patients will be included in each group to reliably detect a difference in mean LDL of 0.5 mmol/L and in mean systolic blood pressure of 5 mmHg. Results: The study is ongoing and recruitment of participants will continue until December 31, 2014. Conclusions: This study will test the hypothesis that a nurse-led, long-term follow-up after an ACS with a focus on achieving treatment goals as soon as possible is an effective secondary preventive method. If proven effective, this method could be implemented in general practice at a low cost.
- 15 August 2014
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 3 (3) , e42
Open AccessThe Nurse-Based Age Independent Intervention to Limit Evolution of Disease After Acute Coronary Syndrome (NAILED ACS) Risk Factor Trial: Protocol for a Randomized Controlled Trial
Background: Secondary prevention after acute coronary syndrome (ACS) is essential to reduce morbidity and mortality, but related studies have been fairly small or performed as clinical trials with non-representative patient selection. Long-term follow-up data are also minimal. A nurse-led follow-up for risk factor improvement may be effective, but the evidence is limited. Objective: The aims of this study are to perform an adequately sized, nurse-led, long-term secondary preventive follow-up with inclusion of an unselected population of ACS patients. The focus will be on lipid and blood pressure control as well as tobacco use and physical activity. Methods: The study will consist of a randomized, controlled, long-term, population-based trial with two parallel groups. Patients will be included during the initial hospital stay. Important outcome variables are total cholesterol, low-density lipoprotein (LDL) cholesterol, and sitting systolic and diastolic blood pressure. Outcomes will be measured after 12, 24, and 36 months of follow-up. Trained nurses will manage the intervention group with the aim of achieving set treatment goals as soon as possible. The control group will receive usual care. At least 250 patients will be included in each group to reliably detect a difference in mean LDL of 0.5 mmol/L and in mean systolic blood pressure of 5 mmHg. Results: The study is ongoing and recruitment of participants will continue until December 31, 2014. Conclusions: This study will test the hypothesis that a nurse-led, long-term follow-up after an ACS with a focus on achieving treatment goals as soon as possible is an effective secondary preventive method. If proven effective, this method could be implemented in general practice at a low cost.
- Open Access
- 1 January 2014
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Quality and Outcomes
- Vol. 7 (1) , 95-101
Risk of Ischemic Stroke After an Acute Myocardial Infarction in Patients With Diabetes Mellitus
Background—Incidence, any trend over time, and predictors of ischemic stroke after an acute myocardial infarction (AMI) in diabetic patients are unknown. Methods and Results—Data for 173 233 unselected patients with an AMI, including 33 503 patients with diabetes mellitus, were taken from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admissions (RIKS-HIA) during 1998 to 2008. Ischemic stroke events were recorded during 1 year of follow-up. Patients with diabetes mellitus more often had a history of cardiovascular disease, received less reperfusion therapy, and were treated with acetylsalicylic acid, P2Y12 inhibitors, and statins to a lesser extent compared with patients without diabetes mellitus. However, the use of evidence-based therapies increased markedly in both groups during the study period. The incidence of ischemic stroke during the first year after AMI decreased from 7.1% to 4.7% in patients with diabetes mellitus and from 4.2% to 3.7% in patients without diabetes mellitus. Risk reduction was significantly larger in the diabetic subgroup. Reperfusion therapy, acetylsalicylic acid, P2Y12 inhibitors, and statins were independently associated with the reduced stroke risk. Conclusions—Ischemic stroke is a fairly common complication after an AMI in patients with diabetes mellitus, but the risk of stroke has decreased during recent years. The increased use of evidence-based therapies contributes importantly to this risk reduction, but there is still room for improvement.
- 1 January 2014
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Quality and Outcomes
- Vol. 7 (1) , 95-101
Open AccessRisk of Ischemic Stroke After an Acute Myocardial Infarction in Patients With Diabetes Mellitus
Background—Incidence, any trend over time, and predictors of ischemic stroke after an acute myocardial infarction (AMI) in diabetic patients are unknown. Methods and Results—Data for 173 233 unselected patients with an AMI, including 33 503 patients with diabetes mellitus, were taken from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admissions (RIKS-HIA) during 1998 to 2008. Ischemic stroke events were recorded during 1 year of follow-up. Patients with diabetes mellitus more often had a history of cardiovascular disease, received less reperfusion therapy, and were treated with acetylsalicylic acid, P2Y12 inhibitors, and statins to a lesser extent compared with patients without diabetes mellitus. However, the use of evidence-based therapies increased markedly in both groups during the study period. The incidence of ischemic stroke during the first year after AMI decreased from 7.1% to 4.7% in patients with diabetes mellitus and from 4.2% to 3.7% in patients without diabetes mellitus. Risk reduction was significantly larger in the diabetic subgroup. Reperfusion therapy, acetylsalicylic acid, P2Y12 inhibitors, and statins were independently associated with the reduced stroke risk. Conclusions—Ischemic stroke is a fairly common complication after an AMI in patients with diabetes mellitus, but the risk of stroke has decreased during recent years. The increased use of evidence-based therapies contributes importantly to this risk reduction, but there is still room for improvement.
- 1 November 2013
- Published by Wolters Kluwer Health in Stroke
- Vol. 44 (11) , 3050-3055
Mortality After Ischemic Stroke in Patients With Acute Myocardial Infarction
Background and Purpose—: Acute myocardial infarction (AMI) increases the risk of ischemic stroke, and mortality among these patients is high. Here, we aimed to estimate the 1-year mortality reliably after AMI complicated by ischemic stroke. We also aimed to identify trends over time for mortality during 1998–2008, as well as factors that predicted increased or decreased mortality. Methods—: Data for 173 233 unselected patients with AMI were collected from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admissions registry for 1998–2008. Specifically, we analyzed 1-year follow-up and mortality data for patients with AMI with and without ischemic stroke. Kaplan–Meyer analysis was used to analyze mortality trends over time, and Cox regression analysis was used to identify uni- and multivariate predictors of mortality. Results—: The 1-year mortality was 36.5% for AMI complicated by ischemic stroke and 18.3% for AMI without stroke. Mortality decreased over time in patients with and without ischemic stroke. The absolute decreases in mortality were 9.4% and 7.5%, respectively. Reperfusion and secondary preventive therapies were associated with a decreased mortality rate. Conclusions—: Mortality after AMI complicated by an ischemic stroke is very high but decreased from 1998 to 2008. The increased use of evidence-based therapies explains the improved prognosis.
- 1 November 2013
- Published by Wolters Kluwer Health in Stroke
- Vol. 44 (11) , 3050-3055
Mortality After Ischemic Stroke in Patients With Acute Myocardial Infarction
Background and Purpose—: Acute myocardial infarction (AMI) increases the risk of ischemic stroke, and mortality among these patients is high. Here, we aimed to estimate the 1-year mortality reliably after AMI complicated by ischemic stroke. We also aimed to identify trends over time for mortality during 1998–2008, as well as factors that predicted increased or decreased mortality. Methods—: Data for 173 233 unselected patients with AMI were collected from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admissions registry for 1998–2008. Specifically, we analyzed 1-year follow-up and mortality data for patients with AMI with and without ischemic stroke. Kaplan–Meyer analysis was used to analyze mortality trends over time, and Cox regression analysis was used to identify uni- and multivariate predictors of mortality. Results—: The 1-year mortality was 36.5% for AMI complicated by ischemic stroke and 18.3% for AMI without stroke. Mortality decreased over time in patients with and without ischemic stroke. The absolute decreases in mortality were 9.4% and 7.5%, respectively. Reperfusion and secondary preventive therapies were associated with a decreased mortality rate. Conclusions—: Mortality after AMI complicated by an ischemic stroke is very high but decreased from 1998 to 2008. The increased use of evidence-based therapies explains the improved prognosis.